We evaluated the usefulness of a rapid antigen detection assay for L7/L12 ribosomal protein (Ribotest Mycoplasma ; Asahi Kasei Pharma) for diagnosis of
Mycoplasma pneumoniae (
M. pneumoniae) infection. Nasopharyngeal swabs were obtained from patients with pneumonia and/or bronchitis ; real-time PCR and the L 7/L12 antigen assays were performed with each sample. Serum was also taken from each patient, and the particle agglutination (PA) method was used to detect anti―
M. pneumoniae antibody in these samples. Macrolide-resistance genes were detected and
M. pneumoniae P1 protein subtyping was performed on PCR positive samples. PCR assays were positive for 85 of 212 specimens (40.1%). Sensitivity and specificity of the L7/L12 antigen assays relative to the PCR standard were 74.1%(63/85) and 81.1%(103/127), respectively. For PCR-positive specimens with a large quantity of
M. pneumoniae nucleic acid, sensitivity of the L7/L12 antigen assays seemed to be high. In PCR-positive specimens with fewer than1.0×10
6 copies/mL of
M. pneumoniae nucleic acid, sensitivity of the L7/L12 antigen assays seemed to be low. When the PA method was used as the standard, the relative sensitivity and specificity of the L7/L12 antigen assays were 41.7%(5/12) and 75.3%(58/77), respectively, for single serum and 60.9%(14/23) and 85.7%(18/21), respectively, for paired sera. The macrolide-resistance gene A2063G was detected in 20 of the 30 tested PCR-positive specimens (66.7%). Of these 20 A2063G-positive specimens, 13(65.0%)were positive for the L7/L12 antigen assays. Tne numbers of
M. pneumoniae P1 subtypes were as follows : types I (22), IIa(2), IIc(1), and untypable (5). The L7/L12 antigen assays gave positive results for 17 of 21(81.0%) subtype I, 1 of 2 (50.0%) IIa, and 1 of 1(100%) IIc specimens.
View full abstract